Background: Numerous cases of the coronavirus disease 2019 (COVID-19) with
autoimmune and rheumatic manifestations have been reported. Despite the available …

Though recent reports link SARS-CoV-2 infections with hyper-inflammatory states in
children, most children experience no/mild symptoms, and hospitalization and mortality rates …

Objective Patients with systemic autoimmune rheumatic diseases (ARDs) continue to be
concerned about risks of severe coronavirus disease 2019 (COVID‐19) outcomes. This …

Objectives To estimate the incidence of COVID-19 hospitalization in patients with
inflammatory rheumatic disease (IRD); in patients with RA treated with specific DMARDs; …

Background In the ongoing COVID-19 pandemic, the susceptibility of patients with rheumatic
diseases to COVID-19 remains unclear. We aimed to investigate susceptibility to COVID-19 …

Background There are limited data regarding the relationship between interstitial lung
disease (ILD) and the natural course of COVID-19. In this study, we investigate whether …

As the coronavirus disease 2019 (COVID-19) pandemic continues worldwide, vaccination
has been considered an effective measure to protect people from the COVID-19 and end the …

Objective In earlier studies, patients with rheumatic and musculoskeletal disease (RMD)
who got infected with COVID-19 had a higher risk of mechanical ventilation than …

Objectives The impact of rheumatic diseases on COVID-19 infection remains poorly
investigated. Here we performed a systematic review and meta-analysis to evaluate the …

Background As the COVID-19 pandemic continues worldwide, severe COVID-19 outcomes
remain a major concern for patients with rheumatic and musculoskeletal diseases. We …